Innovation Accelerator

The Next Frontier: unlocking in-orbit manufacturing of medicines

Posted by: and , Posted on: - Categories: Innovation, Innovation Accelerator, space

The UK is taking steps to support the development and manufacture of innovative medicines in microgravity. Through collaborative work between the Medicines and Healthcare products Regulatory Agency (MHRA) and the UK Space Agency, the UK has published the first dedicated …

The ILAP and the Aligned Pathway – What’s the difference?

Posted by: , Posted on: - Categories: ILAP, Innovation Accelerator, NICE

The Innovative Licensing and Access Pathway (ILAP) and the MHRA-NICE Aligned Pathway both support earlier patient access to safe and effective medicines but they serve different purposes and are accessed at different points in development. The ILAP provides early, coordinated …

The new ILAP TDP: De-risking development by bringing early insights, predictability and improved coordination for developers

Posted by: , Posted on: - Categories: ILAP, Innovation, Innovation Accelerator, TDP

The refreshed Innovative Licensing and Access Pathway (ILAP) is setting a new global benchmark for accelerating patient access to transformative medicines in the UK. More than just a regulatory pathway, the ILAP is the first end-to-end access pathway that brings …